wrong. the minimum bid price requirement stems from Section 5550(a)(2) of the Nasdaq's Equity Rules guide. It clearly states: "(a) Continued Listing Requirements for Primary Equity Securities: (2) Minimum bid price of at least $1 per share."
I have spent hundreds of hours over the past three years completing due diligence on Invivo Therapeutics.... It is also correct that this stock must stay at $4p/s to remain within the NASDQ listing that it currently has...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.